Patients with type 2 diabetes who switched to tirzepatide rather than escalating their dulaglutide dosage had greater weight ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

A new analysis of FDA adverse event reports suggests a potential link between tirzepatide and thyroid cancer. Learn what this ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

From a threshold analysis, the researchers determined that tirzepatide would need a 30.5% reduction in net price to become cost-effective, and semaglutide would need an 81.9% decrease in net price ...

Obesity is a chronic disorder characterized by excessive body weight (body mass index [BMI] ≥ 30 ... Tirzepatide utilization analyses revealed that 88.6% of patients were initiated on 2.5 mg ...

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with ...